Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing.

MLA

Sadegh, Sepideh, et al. “Exploring the SARS-CoV-2 Virus-Host-Drug Interactome for Drug Repurposing.” Nature Communications, vol. 11, no. 1, July 2020, pp. 1–9. EBSCOhost, https://doi.org/10.1038/s41467-020-17189-2.

APA

Sadegh, S., Matschinske, J., Blumenthal, D. B., Galindez, G., Kacprowski, T., List, M., Nasirigerdeh, R., Oubounyt, M., Pichlmair, A., Rose, T. D., Salgado-Albarrán, M., Späth, J., Stukalov, A., Wenke, N. K., Yuan, K., Pauling, J. K., & Baumbach, J. (2020). Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing. Nature Communications, 11(1), 1–9. https://doi.org/10.1038/s41467-020-17189-2

Chicago

Sadegh, Sepideh, Julian Matschinske, David B. Blumenthal, Gihanna Galindez, Tim Kacprowski, Markus List, Reza Nasirigerdeh, et al. 2020. “Exploring the SARS-CoV-2 Virus-Host-Drug Interactome for Drug Repurposing.” Nature Communications 11 (1): 1–9. doi:10.1038/s41467-020-17189-2.